Elevated stress protein in transitional cells exposed to urine from interstitial cystitis patients

International Journal of Urology

Volumn 5, Issue 5, 1998, Pages 444-448

  Ito, Takaaki ^a,b   Stein, Paul C ^a   Parsons, C Lowell ^a   Schmidt, Joseph D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

ELISA; Heat shock protein; Interstitial cystitis; Stress protein; Toxic urine

Indexed keywords

HEAT SHOCK PROTEIN; MONOCLONAL ANTIBODY;

ARTICLE; BIOPSY; BLADDER; BLADDER MUCOSA; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERSTITIAL CYSTITIS; PRIORITY JOURNAL; PROTEIN INDUCTION; URINE; UROTHELIUM;

EID: 0031769529     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2042.1998.tb00385.x     Document Type: Article

References (30)

1. Holm-Bentzen M, Nordling J, Held T. Etiology: etiologic and pathogenetic theories in interstitial cystitis. In: Hanno PM, Staskin DR, Krane RJ, Wein AJ (eds). Interstitial cystitis. London: Springer-Verlag 1990:63-77.
2. Akiyama A, Stein PC, Parson CL. Urothelial cytoprotective activity ofTamm-Horsfall protein from interstitial cystitis and normal urine. J Urol 1997;157(suppl):130.
3. Gill WK, Jones KW, Ruggiero KJ. Prospective effects of heparin and other sulfated glycosaminoglycans on crystal adhesion to urothelium. J Urol 1982;127:152-154.
4. Parsons CL, Danielson B, Feldstorm B. Inhibition of sodium urate crystal adherence to bladder surface by polysaccharide. J Urol 1985;134:614-616.
5. Parsons CL, Greenspan C, Moore SW, Mulholland SG. Role of surface mucin in primary antibacterial defense of bladder. Urology 1977;9:48-52.
6. Parsons CL, Greenspan C, Mulholland SG. The primary antibacterial defense mechanism of the bladder. Invest Urol 1975;13:72-76.
7. Parsons CL, Mulholland SG. Bladder surface mucin: its antibacterial effect against various bacterial species. Am J Pathol 1978;93:423-432.
8. Parsons CL, Stauffer C, Schmidt JD. Bladder surface glycosaminoglycans: an efficient mechanism of environmental adaption. Science 1980;208:605-607.
9. Moskowitz MO, Byrne DS, Callahan HJ, Parsons CL, Valderama E, Moldwin RM. Decreased expression of a glycoprotein component of bladder surface mucin (GP1) in interstitial cystitis. J Urol 1994;151:343-345.
10. Parsons CL, Boychuk D, Jones S, Hurst RE, Callahan HJ. Bladder surface glycosaminoglycans: an epithelial permeability barrier. J Urol 1990;143:139-142.
11. Schlesinger MJ. Heat shock protein. J Biol Chem 1990;265: 12111-12114.
12. Ang D, Liberek K, Skowya D, Zylicz M, Georgopoulos C. Biological role and regulation of the universally conserved heat shock protein. J Biol Chem 1991;266:24233-24326.
13. Welch WJ, Feramisca JR. Purification of the mammalian heat shock proteins. J Biol Chem 1982;257:14949-14959.
14. Parsons CL, Stauffer CW, Schmidt JD. Reversible inactivation of bladder surface glycosaminoglycan antibacterial activity by protamine sulfate. Infect Immun 1988;56:1341-1343.
15. Mizzen LA, Welch WJ. Characterization of the thermotolerant cell. I. Effects of protein synthesis activity and the regulation of heat shock protein 70 expression. J Cell Biol 1988;106:1105-1116.
16. Zhao Y, Levin RM, Monson FC, Chacko S. Expression of constitutive heat shock protein-70 in normal (non-stressed) rabbit urinary bladder tissue. Mol Cell Biochem 1993;121:13-19.
17. Anderson RL, Wang CY, Van Kersen I, Lee KJ, Welch WJ, Lavagnini P, Hahn GM. An immunoassay for heat shock protein 73/72: use of the assay to correlate HSP73/72 levels in mammalian cells with heat response. Int J Hyperthermia 1993;9:539-552.
18. Lilly JD, Parsons CL. Bladder surface glycosaminoglycans is a human permeability barrier. Surg Gynec Obst 1990;171:493-496.
19. Fowler JE Jr, Lynes WL, Lau JLT, Gosh L, Mounzer A. Interstitial cystitis associated with intraurothelial Tamm-Horsfall protein. J Urol 1988;140:1385-1389.
20. Sant GR, Meares EM. Interstitial cystitis: pathogenesis, diagnosis and treatment. Infect Urol 1990;3:24.
21. Hanno PM, Wein AJ. Interstitial cystitis. Part I and II. AUA update series, 1987; vol. 6, lesson 9 and 10.
22. Clemmensen O, Lose G, Holm-Bentzen M, Colstrup H. Skin reaction to urine in patients with interstitial cystitis. Urology 1988;32:17-20.
23. Parsons CL, Stein PC. Role of toxic urine in interstitial cystitis. J Urol 1990;143:373A.
24. Beier-Holgersen R, Hermann GG, Mortensen SO, Steven K. The in-vitro cytotoxicity of urine from patients with interstitial cystitis. J Urol 1994;151:206-207.
25. Dixon JS, Holm-Bentzen M, Gilpin CJ, Gosling JA, Bostofte E, Hald T, Larsen S. Electron microscopic investigation of the bladder urothelium and glycocalyx in patients with interstitial cystitis. J Urol 1986;135:621-625.
26. Sant GR, Uoci AA Jr, Alroy J. Bladder surface glycosaminoglycans (GAGs) in interstitial cystitis. J Urol 1986; 135:175A.
27. Hurst RE, Roy JB, Bynum RJ, Parry WL. Abnormal glycosaminoglycans excretion in patients with chronic interstitial cystitis. J Urol 1985;133:144A.
28. Holm-Bentzen M, Ammitzboll T, Hald T. Glycosaminoglycan on the surface of the human urothelium: a preliminary report. Neurourol Urodyn 1986;5:519-523.
29. Parsons CL, Lilly JD, Stein PC. Epithelial dysfunction in nonbacterial cystitis (interstitial cystitis). J Urol 1991; 145:732-735.
30. Parsons CL, Schmidt JD, Pollen JJ. Successful treatment of interstitial cystitis with pentosanpolysulfate. J Urol 1983;130:51-53.